Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression
- PMID: 26837693
- PMCID: PMC4736169
- DOI: 10.1186/s13000-016-0467-5
Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression
Abstract
Background: Ovarian clear cell carcinoma (CCC) is an uncommon subtype of ovarian epithelial tumor. The prognostic significance of its clinicopathological parameters is discordant, with the exception of stage as the adverse prognostic factor. The present study aimed to evaluate the prognostic significance of its clinicopathological characteristics and the expression of IMP3 (Insulin-like growth factor-II mRNA-binding protein 3, IMP3 or IGF2BP3) in Chinese patients with primary pure CCC.
Methods: We collected clinicopathological data from 73 cases with a minimum of 5 years of follow-up and evaluated the expression of IMP3 by immunohistochemistry.
Results: In total, 49.3 % of the patients were in stage I. Advanced stages were closely related to poor prognosis of disease-free survival (DFS) and overall survival (OS) (P < 0.005). Patients with CCC coexisting with endometriosis tended to be younger and to have unilateral involvement but did not exhibit differences in prognosis compared with patients with CCC without endometriosis. Other histological features such as growth pattern, mitosis, and necrosis did not have prognostic significance. IMP3 was positive in 63 % of patients (46 of 73 cases); Thus, positive expression of IMP3 is an adverse prognostic marker in terms of OS (P = 0.012), even in stage I patients (P = 0.038).
Conclusions: The present study demonstrates that IMP3 expression is a prognostic marker, with the exception of stage. IMP3 represents a biomarker of unfavorable prognosis even in stage I patients.
Figures
Similar articles
-
Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.Int J Clin Exp Pathol. 2015 May 1;8(5):5642-9. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191276 Free PMC article.
-
The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.Pathol Res Pract. 2018 Aug;214(8):1087-1094. doi: 10.1016/j.prp.2018.05.026. Epub 2018 May 29. Pathol Res Pract. 2018. PMID: 29866423
-
Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer.Br J Cancer. 2015 Jul 28;113(3):414-24. doi: 10.1038/bjc.2015.254. Epub 2015 Jul 9. Br J Cancer. 2015. PMID: 26158423 Free PMC article.
-
Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.Oncology (Williston Park). 2016 Feb;30(2):166-76. Oncology (Williston Park). 2016. PMID: 26892153 Review.
-
Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous carcinoma.Am Soc Clin Oncol Educ Book. 2013. doi: 10.14694/EdBook_AM.2013.33.e200. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714502 Review.
Cited by
-
Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort.Medicine (Baltimore). 2018 May;97(21):e10881. doi: 10.1097/MD.0000000000010881. Medicine (Baltimore). 2018. PMID: 29794794 Free PMC article.
-
IGF2BP3 promotes glutamine metabolism of endometriosis by interacting with UCA1 to enhances the mRNA stability of GLS1.Mol Med. 2024 May 17;30(1):64. doi: 10.1186/s10020-024-00834-7. Mol Med. 2024. PMID: 38760723 Free PMC article.
-
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.Diagn Pathol. 2023 Feb 6;18(1):15. doi: 10.1186/s13000-023-01300-4. Diagn Pathol. 2023. PMID: 36740684 Free PMC article.
-
Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.Onco Targets Ther. 2017 Jun 6;10:2849-2863. doi: 10.2147/OTT.S128810. eCollection 2017. Onco Targets Ther. 2017. PMID: 28652767 Free PMC article.
-
IGF2BP3 May Contributes to Lung Tumorigenesis by Regulating the Alternative Splicing of PKM.Front Bioeng Biotechnol. 2020 Sep 2;8:679. doi: 10.3389/fbioe.2020.00679. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32984260 Free PMC article.
References
-
- Han G, Gilks CB, Leung S, Ewanowich CA, Irving JA, Longacre TA, et al. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases. Am J Surg Pathol. 2008;32:955–64. doi: 10.1097/PAS.0b013e318164edf7. - DOI - PubMed
-
- Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer. 2000;88:2584–9. doi: 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical